{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:19:36Z","timestamp":1760833176473,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.nmd.2004.04.004","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T15:10:35Z","timestamp":1090595435000},"page":"456-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Concerns about the design of clinical trials for spinal muscular atrophy"],"prefix":"10.1016","volume":"14","author":[{"given":"Thomas O.","family":"Crawford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2004.04.004_BIB1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.10050","article-title":"Motor unit number estimation in infants and children with spinal muscular atrophy","volume":"25","author":"Bromberg","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2004.04.004_BIB2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/87.4.707","article-title":"Infantile muscular atrophy: a prospective study with particular reference to a slowly progressive variety","volume":"87","author":"Dubowitz","year":"1964","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2004.04.004_BIB3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/088307380001500207","article-title":"Prospective analysis of strength in spinal muscular atrophy","volume":"15","author":"Iannaccone","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2004.04.004_BIB5","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0960-8966(01)00272-3","article-title":"90th ENMC International Workshop: European spinal muscular atrophy randomised trial (EuroSMART) 9\u201310 February 2001, Naarden, The Netherlands","volume":"12","author":"Merlini","year":"2002","journal-title":"Neuromuscul Dis"},{"issue":"Suppl","key":"10.1016\/j.nmd.2004.04.004_BIB6","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1097\/00002060-199509001-00009","article-title":"Profiles of neuromuscular diseases. Spinal muscular atrophy","volume":"74","author":"Carter","year":"1995","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2004.04.004_BIB7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2004.04.004_BIB8","series-title":"Principles and practice of clinical research","first-page":"207","article-title":"Small clinical trials","author":"Max","year":"2002"},{"key":"10.1016\/j.nmd.2004.04.004_BIB9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","article-title":"Pilot trial of albuterol in spinal muscular atrophy","volume":"59","author":"Kinali","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2004.04.004_BIB10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0955-0674(02)00332-0","article-title":"The SMN complex, an assemblyosome of ribonucleoproteins","volume":"14","author":"Paushkin","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.152.5.1107","article-title":"Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy","volume":"152","author":"Cifuentes-Diaz","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archneur.1979.00500400056008","article-title":"Amyotrophic lateral sclerosis: impairment of neuromuscular transmission","volume":"36","author":"Denys","year":"1979","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Cifuentes-Diaz","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2004.04.004_BIB14","series-title":"Disorders of voluntary muscle","first-page":"238","article-title":"Pathological anatomy of the intramuscular motor innervation","author":"Co\u00ebrs","year":"1981"},{"key":"10.1016\/j.nmd.2004.04.004_BIB15","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1152\/jn.00270.2002","article-title":"Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease","volume":"88","author":"Rich","year":"2002","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/mus.880130214","article-title":"Electromyographic and morphological functional compensation in late poliomyelitis","volume":"13","author":"Einarsson","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2004.04.004_BIB17","first-page":"716","article-title":"Electrophysiological findings in childhood spinal muscular atrophies","volume":"144","author":"Hausmanowa-Petrusewicz","year":"1988","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nmd.2004.04.004_BIB18","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/hmg\/11.14.1605","article-title":"Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development","volume":"11","author":"Fan","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2004.04.004_BIB19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/mus.1128","article-title":"Depletion and sizes of motor units in spinal muscular atrophy","volume":"24","author":"Galea","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2004.04.004_BIB20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0887-8994(96)00123-3","article-title":"Synaptic alterations of anterior horn cells in Werdnig-Hoffmann disease","volume":"15","author":"Yamanouchi","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U","article-title":"Abnormal fatty acid metabolism in childhood spinal muscular atrophy","volume":"45","author":"Crawford","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/08830738030180080501","article-title":"Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study","volume":"18","author":"Merlini","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","article-title":"A placebo-controlled trial of gabapentin in spinal muscular atrophy","volume":"191","author":"Miller","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2004.04.004_BIB24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2004.04.004_BIB25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00002060-200009000-00005","article-title":"A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report","volume":"79","author":"Tzeng","year":"2000","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2004.04.004_BIB26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/088307389400900313","article-title":"Efficacy of thyrotrophin-releasing hormone in the treatment of spinal muscular atrophy","volume":"9","author":"Takeuchi","year":"1994","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2004.04.004_BIB27","first-page":"460","article-title":"Guanidine hydrochloride in infantile and juvenile spinal muscular atrophy. A double blind controlled study","volume":"2","author":"Angelini","year":"1980","journal-title":"Acta Neurol (Napoli)"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896604000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896604000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:53:03Z","timestamp":1760773983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896604000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":27,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0960896604000975"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2004.04.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concerns about the design of clinical trials for spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2004.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}